<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dart RJ</submitter><funding>Cancer Research UK</funding><funding>Medical Research Council</funding><funding>The Francis Crick Institute</funding><funding>National Institute for Health Research (NIHR)</funding><funding>Wellcome Trust</funding><pagination>eadh0301</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7615126</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>381(6663)</volume><pubmed_abstract>Murine intraepithelial γδ T cells include distinct tissue-protective cells selected by epithelial butyrophilin-like (BTNL) heteromers. To determine whether this biology is conserved in humans, we characterized the colonic γδ T cell compartment, identifying a diverse repertoire that includes a phenotypically distinct subset coexpressing T cell receptor Vγ4 and the epithelium-binding integrin CD103. This subset was disproportionately diminished and dysregulated in inflammatory bowel disease, whereas on-treatment CD103&lt;sup>+&lt;/sup>γδ T cell restoration was associated with sustained inflammatory bowel disease remission. Moreover, CD103&lt;sup>+&lt;/sup>Vγ4&lt;sup>+&lt;/sup>cell dysregulation and loss were also displayed by humans with germline BTNL3/BTNL8 hypomorphism, which we identified as a risk factor </pubmed_abstract><journal>Science (New York, N.Y.)</journal><pubmed_title>Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease.</pubmed_title><pmcid>PMC7615126</pmcid><funding_grant_id>FC001093</funding_grant_id><funding_grant_id>108745</funding_grant_id><funding_grant_id>CC2012</funding_grant_id><funding_grant_id>094491/Z/10/Z</funding_grant_id><funding_grant_id>106292/Z/14/Z</funding_grant_id><funding_grant_id>FC001003</funding_grant_id><funding_grant_id>108745/Z/15/Z</funding_grant_id><funding_grant_id>100156</funding_grant_id><funding_grant_id>100156/Z/12/Z</funding_grant_id><funding_grant_id>CL-2014-01-005</funding_grant_id><funding_grant_id>CC1107</funding_grant_id><funding_grant_id>106292</funding_grant_id><pubmed_authors>Kannambath S</pubmed_authors><pubmed_authors>Amar A</pubmed_authors><pubmed_authors>East P</pubmed_authors><pubmed_authors>Zlatareva I</pubmed_authors><pubmed_authors>Theodoridis E</pubmed_authors><pubmed_authors>Dart RJ</pubmed_authors><pubmed_authors>Hayday AC</pubmed_authors><pubmed_authors>Parkes M</pubmed_authors><pubmed_authors>Recaldin T</pubmed_authors><pubmed_authors>Lamb CA</pubmed_authors><pubmed_authors>Mansfield JC</pubmed_authors><pubmed_authors>Irving PM</pubmed_authors><pubmed_authors>Prescott NJ</pubmed_authors><pubmed_authors>Vantourout P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease.</name><description>Murine intraepithelial γδ T cells include distinct tissue-protective cells selected by epithelial butyrophilin-like (BTNL) heteromers. To determine whether this biology is conserved in humans, we characterized the colonic γδ T cell compartment, identifying a diverse repertoire that includes a phenotypically distinct subset coexpressing T cell receptor Vγ4 and the epithelium-binding integrin CD103. This subset was disproportionately diminished and dysregulated in inflammatory bowel disease, whereas on-treatment CD103&lt;sup>+&lt;/sup>γδ T cell restoration was associated with sustained inflammatory bowel disease remission. Moreover, CD103&lt;sup>+&lt;/sup>Vγ4&lt;sup>+&lt;/sup>cell dysregulation and loss were also displayed by humans with germline BTNL3/BTNL8 hypomorphism, which we identified as a risk factor </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Sep</publication><modification>2026-05-29T00:23:08.988Z</modification><creation>2024-11-07T04:12:46.415Z</creation></dates><accession>S-EPMC7615126</accession><cross_references><pubmed>37708268</pubmed><doi>10.1126/science.adh0301</doi></cross_references></HashMap>